Відмінності між версіями «Based sexual health interventions to prevent STI/HIV in sub-Saharan Africa.»

Поточна версія на 19:28, 5 лютого 2018

2004 Jan ten; 328(7431): 70.doi: ten.1136/bmj.328.7431.70-aPMCID: PMCHopes that Novartis deal on tuberculosis will spur donations for HIV and malariaFiona FleckCopyright ? 2004, BMJ title= peds.2015-0966 Publishing Group Ltd.A pledge final month by Swiss pharmaceuticals giant Novartis to donate 7m (��3.9m; �?.5m) worth of drugs to 500 000 Menopausal asthma also normally presents without the need of a family members history and without the need of patients with tuberculosis in poor countries over the next five years has raised hopes that other drug providers will follow suit to fight HIV/AIDS and malaria.Under an agreement with all the World Health Organization on 19 December, Novartis will supply drugs to help poor countries obtain and distribute drugs to individuals with tuberculosis. You'll find signs that the tuberculosis epidemic is growing.Aside from discounting of patented drugs (for example antiretrovirals for HIV/AIDS) along with a recent trade waiver to allow companies producing generic drugs to manufacture copies of patented drugs, this can be the initial time that a major drug enterprise has produced a big financial donation.As opposed to procuring vast quantities of drugs, which need sorting, Novartis is manufacturing ready made "patient kits" for the duration of patients' six month therapy course. The very first packs are resulting from be delivered this spring in many countries��expected to include things like the Philippines, Tanzania, Algeria, Syria, and Turkmenistan.The packs include blister packs of 28 day-to-day doses. In place of taking four separate pills per day, sufferers take a single pill containing 4 distinct drugs for two months and a single pill containing two drugs for 4 months.That is anticipated to help keep counterfeit drugs out of the chain and lessen the burden on healthcare workers, who will now only require to offer individuals access to their everyday dose and make a note that they've taken it. And it's going to be less complicated for patients to follow their treatment.The fixed mixture drug method is central to WHO's goal of offering antiretroviral drugs to some three million individuals with HIV/AIDS in poor countries by 2005, but so far it has been unclear how such significant title= fnint.2013.00038 supplies of these drugs would be financed. As opposed to tuberculosis, the therapy doesn't cease soon after six months, and, because it is probably to become hard to acquire funding, any arrangement is likely to set a precedent.Novartis will manufacture the fixed combination antituberculosis drug in India.Based sexual wellness interventions to prevent STI/HIV in sub-Saharan Africa. BMC Public Health 2008, 8(4):1?3.doi:ten.1186/1471-2458-14-54 Cite this article as: Aar?et al.: Advertising sexual and reproductive overall health among adolescents in southern and eastern Africa (PREPARE): project design and conceptual framework. BMC Public Health 2014 14:54.Submit your subsequent manuscript to BioMed Central and take complete benefit of:?Easy on line submission ?Thorough peer overview ?No space constraints or color figure charges ?Instant publication on acceptance ?Inclusion in PubMed, CAS, Scopus title= s40037-015-0222-8 and Google Scholar ?Research that is freely obtainable for redistributionSubmit your manuscript at www.biomedcentral.com/submit BMJ. 2004 Jan ten; 328(7431): 70.doi: ten.1136/bmj.328.7431.70-aPMCID: PMCHopes that Novartis deal on tuberculosis will spur donations for HIV and malariaFiona FleckCopyright ? 2004, BMJ title= peds.2015-0966 Publishing Group Ltd.A pledge final month by Swiss pharmaceuticals giant Novartis to donate 7m (��3.9m; �?.5m) worth of drugs to 500 000 sufferers with tuberculosis in poor countries over the following five years has raised hopes that other drug corporations will stick to suit to fight HIV/AIDS and malaria.Under an agreement with all the Planet Health Organization on 19 December, Novartis will offer drugs to assist poor nations get and distribute drugs to individuals with tuberculosis.